Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

GLakefront Biotherapeutics NV

EconomyAI buildoutMarket MapFundsWatchlist
Log in
G

Lakefront Biotherapeutics NV

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Fiscal Q2 2021Jun 30, 2021
Fiscal Q2 2020Jun 30, 2020
Fiscal Q2 2019Jun 30, 2019
Fiscal Q2 2018Jun 30, 2018
Fiscal Q2 2017Jun 30, 2017
Money the company earns from selling products or services, before subtracting costs.
+48.7% YoY+67.4% YoY+15.6% YoY+88.2% YoY
The costs of running the business beyond making or delivering its products, such as research, marketing, and office expenses.
+4.9% YoY+78.0% YoY+20.6% YoY+68.9% YoY
Profit from the company’s main business, before taxes and income or costs outside those operations.Formula: Gross profit − operating expenses
+43.8% YoY-96.3% YoY-28.6% YoY-58.9% YoY
Money earned or spent outside the main business, such as investment income and interest on debt.Formula: Non-operating income − non-operating expenses
+32.2% YoY-895.6% YoY
Profit before income taxes are taken out.Formula: Operating income + net non-operating income + pre-tax adjustments
+41.0% YoY-144.1% YoY-112.7% YoY+37.7% YoY
The income tax cost counted against the period’s profit, including amounts payable now or later.
+503.9% YoY-20.5% YoY-16.8% YoY
The profit left after all expenses and taxes. A negative number means the company lost money.Formula: Total income − total expenses
+40.8% YoY-140.5% YoY-112.2% YoY+37.7% YoY